3rd Annual VISTA Symposium: VISTA – Clinical updates and biological insights on a promising new target in cancer immunotherapy
| DATE: | March 27, 2024 |
|---|---|
| TIME: | 11:00 AM EDT |
| LOCATION: | Virtual |
About The Event
With anticipation building for the first clinical readouts expected later in 2024, join Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine for the 3rd annual virtual VISTA symposium, where renowned scientific experts and industry leaders will convene to explore the important emerging role of VISTA in cancer immunotherapy.
The VISTA Symposium 2024 will review the latest insights on VISTA biology, the growing potential of VISTA as a therapeutic target in multiple cancer indications and share updates on the ongoing clinical development of anti-VISTA therapies.
Short presentations, panel discussions and Q&A sessions will contextualize the exciting data that demonstrates why VISTA is a target to watch in 2024!
Agenda
Opening Remarks (11:00 AM – 11:10 AM ET)
- Piers Ingram, PhD – Chief Executive Officer and Co-Founder, Hummingbird Bioscience
Keynote (11:10 AM – 11:30 AM ET)
- John Connolly, PhD – Chief Scientific Officer, Parker Institute for Cancer Immunotherapy
VISTA Biology (11:30 AM – 12:30 PM ET)
- Randolph Noelle, PhD – Emeritus Professor of Microbiology and Immunology, Geisel School of Medicine
- Louise Lines, PhD – Research Scientist, Geisel School of Medicine
- Li Lily Wang, PhD – Associate Staff, Lerner Research Institute, Cleveland Clinic
- Sietse J. Luk, MD – Research Scientist, Department of Hematology, Leiden University Medical Center
VISTA Targeting and Potential Biomarkers (12:30 PM – 1:15 PM ET)
- Bhushan Dharmadhikari, PhD – Principal Scientist, Hummingbird Bioscience
- Sven Mostböck, PhD – Principal Scientist, Boehringer Ingelheim
- Robert Martell, MD, PhD – Chief Scientific Officer, Curis
VISTA and Clinical Opportunities (1:30 PM – 2:30 PM ET)
- Joshua Gruber, MD, PhD – Assistant Professor, Department of Internal Medicine, University of Texas, Southwestern Medical Center
- Jack Hoopes, DVM, PhD – Professor of Surgery, Professor of Medicine, Geisel School of Medicine
- Jing Fu, PhD – Research Scientist, Vagelos College of Physicians and Surgeons, Columbia University
- Matthew Vesely, MD, PhD – Assistant Professor of Dermatology, Yale School of Medicine
Anti-VISTA Immunotherapies in Clinical Development (2:30 PM – 3:30 PM ET)
- Edward van der Horst, PhD – Chief Scientific Officer, Sensei Bio
- Jerome Boyd-Kirkup, PhD – Chief Scientific Officer and Co-Founder, Hummingbird Bioscience
- Thierry Guillaudeux, PhD – Chief Scientific Officer, Kineta